eFinder

eFinder

AI-designed miniproteins switch key cell receptors on and off


Researchers from the UW Medicine Institute for Protein Design and Skape Bio have developed AI-designed miniproteins capable of activating or blocking G protein-coupled receptors (GPCRs). The study, published in Nature, also introduces a new screening system to test these proteins within living human cells to accelerate drug discovery.

analyticsAnalysis

10%
Propaganda Score
confidence: 95%
Low risk. This article shows minimal use of propaganda techniques.

fact_checkFact-Check Results

11 claims extracted and verified against multiple sources including cross-references, web search, and Wikipedia.

check_circle Corroborated 5
info Single Source 3
help Insufficient Evidence 2
schedule Pending 1
check_circle
“G protein-coupled receptors, or GPCRs, sit in the plasma membrane, the boundary that defines the inside and outside of a living cell.”
CORROBORATED
Multiple independent educational and reference sources (Britannica, GeeksforGeeks, and a specialized search result) confirm that GPCRs are located in the cell membrane.
travel_explore
web search NEUTRAL — G protein-coupled receptor (GPCR), protein located in the cell membrane that binds extracellular substances and transmits signals from these substances to an intracellular molecule called a G protein …
https://www.britannica.com/science/G-protein-coupled-recepto…
travel_explore
web search NEUTRAL — G protein-coupled receptors (GPCRs) are seven-transmembrane proteins found in cell membranes, with their N- and C-termini situated on the exterior and interior surfaces, respectively. The extracellula…
https://www.geeksforgeeks.org/biology/g-protein-coupled-rece…
travel_explore
web search NEUTRAL — G protein-coupled receptors (GPCRs) are located in the cell membrane of eukaryotic organisms including animals, plants, yeast and choanoflagellates. Each GPCR is made up of a single polypeptide that’s…
https://www.aatbio.com/resources/faq-frequently-asked-questi…
info
“The UW Medicine Institute for Protein Design and Skape Bio led a new study showing for the first time that AI can be used to create computationally designed proteins to activate or block GPCRs.”
SINGLE SOURCE
While evidence confirms David Baker's role at the Institute for Protein Design, the specific study involving Skape Bio and AI-designed proteins to activate/block GPCRs is not explicitly detailed in the provided search results, though related work on GPCR miniproteins is mentioned.
travel_explore
web search NEUTRAL — David Baker, of UW Medicine's Institute for Protein Design, describes why protein design is vital to the future of healthcare.#uwmedicinenewsroom.
https://www.youtube.com/watch?v=5CbQVPJq3II
travel_explore
web search NEUTRAL — demonstrated the vaccine produced a strong immune response.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6…
travel_explore
web search NEUTRAL — Únete para ver lo que te estás perdiendoEncuentra a personas que conoces en Institute for Protein Design, University of WashingtonConsulta empleos recomendados para ti
https://es.linkedin.com/company/uwproteindesign
info
“Their findings are published in Nature.”
SINGLE SOURCE
The provided web results for this claim are generic study-help websites and do not contain any information regarding a publication in the journal Nature.
travel_explore
web search NEUTRAL — Need a Study.com Account? Simple & engaging videos to help you learn Unlimited access to 88,000+ lessons The lowest-cost way to earn college credit
https://study.com/academy/login.html
travel_explore
web search NEUTRAL — STUDY4 - học tiếng Anh và luyện thi online TOEIC, IELTS, SAT, ACT, GRE, GMAT.
https://study4.com/
travel_explore
web search NEUTRAL — Master any subject with Studley AI. Trusted by more than 2,000,000 top students. Create beautiful and interactive notes, flashcards, quizzes and podcasts from any content. Study smarter, not harder.
https://www.studley.ai/
check_circle
“David Baker [is] director of the UW Medicine Institute for Protein Design.”
CORROBORATED
Multiple independent sources (TIME, UW Medicine, and a Nobel Prize announcement) confirm David Baker is the director of the UW Medicine Institute for Protein Design.
travel_explore
web search NEUTRAL — David Baker, of UW Medicine's Institute for Protein Design, describes why protein design is vital to the future of healthcare.#uwmedicinenewsroom.
https://www.youtube.com/watch?v=5CbQVPJq3II
travel_explore
web search NEUTRAL — Protein design pioneer David Baker was named to the inaugural TIME100 Health list. Baker is a professor of biochemistry at the University of Washington School of Medicine and director of the UW Medici…
https://newsroom.uw.edu/blog/time-honors-protein-designer-da…
travel_explore
web search NEUTRAL — University of Washington biochemist David Baker has won a share of this year's Nobel Prize in chemistry for deciphering protein structures.
https://www.geekwire.com/2024/uw-david-baker-nobel-chemistry…
check_circle
“Baker... is a professor of biochemistry at the University of Washington School of Medicine and a Howard Hughes Medical Institute Investigator.”
CORROBORATED
Multiple sources confirm David Baker is both a professor of biochemistry at the University of Washington and a Howard Hughes Medical Institute Investigator.
travel_explore
web search NEUTRAL — Hughes withdrew from Rice University shortly after his father's death. On June 1, 1925, he married Ella Botts Rice, daughter of David Rice and Martha Lawson Botts of Houston, and great-niece of Willia…
https://en.wikipedia.org/wiki/Howard_Hughes
travel_explore
web search NEUTRAL — David Baker is the director of the Institute for Protein Design, a Howard Hughes Medical Institute Investigator, a professor of biochemistry, and an adjunct professor of genome sciences, bioengineerin…
https://www.mscottbrauer.com/portraits-david-baker-nobel-uw-…
travel_explore
web search NEUTRAL — David is a biochemistry professor at the University of Washington, a Howard Hughes Medical Institute investigator, and the director of The Institute for Protein Design at the University of Washington.
https://timmermanreport.com/2019/12/designer-proteins-as-bet…
check_circle
“The team developed specialized design strategies to build miniproteins (proteins with fewer than 100 amino acids) that can slip into these hard-to-access sites.”
CORROBORATED
Sources confirm the use of de novo design for miniproteins targeting GPCRs and define miniproteins as being smaller than 100 amino acids.
travel_explore
web search NEUTRAL — Miniproteins – small but mighty! Proteins come in all shapes and sizes, ranging from thousands of amino acids in length to less than 20.There are numerous miniproteins in development for healthcare ap…
https://www.blopig.com/blog/2021/01/miniproteins-small-but-m…
travel_explore
web search NEUTRAL — De novo design enables creation of potent, selective miniproteins targeting GPCRs, advancing precision drug discovery.Researchers Developed Computational Methods to Target GPCR Epitopes.
https://cbirt.net/designer-miniproteins-new-frontier-in-gpcr…
travel_explore
web search NEUTRAL — Researchers have been exploring the new universe of mini proteins with variable functions.Researchers in the past typically excluded any ORF that would yield a protein smaller than 100 amino acids in …
https://www.ibtimes.sg/scientists-scratch-new-universe-minip…
info
“In one mouse study, a designed miniprotein performed comparably to a clinically used drug while showing fewer side effects.”
SINGLE SOURCE
General evidence discusses miniproteins having reduced immunogenicity or high affinity, but the specific mouse study comparing a designed miniprotein to a clinical drug with fewer side effects is not explicitly detailed in the provided snippets.
travel_explore
web search NEUTRAL — Miniproteins are designed based on protein structure information and optimized to enhance their affinity and stability. The optimized miniproteins can exhibit high affinity for their target proteins, …
https://www.nature.com/articles/s41392-024-02010-z?error=coo…
travel_explore
web search NEUTRAL — The researchers employed advanced computational protein design methods to create miniproteins, approximately 60 amino acids in length, capable of binding with high affinity to IL-23R and IL-17A.
https://medium.com/@axialxyz/preclinical-proof-of-principle-…
travel_explore
web search NEUTRAL — A recent paper by David Baker’s group put miniproteins into the spotlight, as the study authors were able to design miniproteins that bind the SARS-CoV-2 spike protein with as strong affinity as an an…
https://www.blopig.com/blog/2021/01/miniproteins-small-but-m…
check_circle
“Edin Muratspahić [is] an Institute for Protein Design postdoctoral research scholar and a first author of the study.”
CORROBORATED
LinkedIn and X (Twitter) profiles, as well as a prize announcement, confirm Edin Muratspahić is a postdoctoral research scholar at the Institute for Protein Design in the Baker lab.
travel_explore
web search NEUTRAL — Postdoctoral Research Scholar · Berufserfahrung: Institute for Protein Design, University of Washington · Ausbildung: Medizinische Universität Wien · Standort: Wien · 500+ Kontakte auf LinkedIn.
https://at.linkedin.com/in/edin-muratspahic-2b2b22141
travel_explore
web search NEUTRAL — Edin Muratspahić's research work will focus on the computer-based design of allosteric peptide modulators of G protein-coupled receptors, which is a highly topical area of research. Publication: Journ…
https://www.meduniwien.ac.at/web/en/about-us/news/2022/news-…
travel_explore
web search NEUTRAL — Edin Muratspahic (@EdinMuratspahic) on X. Erwin Schrödinger Postdoctoral Fellow in the Baker lab at the Institute for Protein Design, University of Washington.
https://twitter.com/EdinMuratspahic
help
“the researchers also invented a new screening system... By working directly in living human cells, the new system can test tens of thousands of proteins against GPCRs while keeping the receptors in the cell membrane.”
INSUFFICIENT EVIDENCE
No evidence was provided in the search results regarding the invention of this specific screening system.
help
“Christoffer Norn [is] corresponding author and co-founder of Skape Bio.”
INSUFFICIENT EVIDENCE
No evidence was provided in the search results regarding Christoffer Norn's role as corresponding author or co-founder of Skape Bio.
schedule
“De novo design of miniproteins targeting G protein-coupled receptors, Nature (2026). DOI: 10.1038/s41586-026-10656-8”
PENDING

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.